Assignee
ANTISENSE THERAPEUTICS LTD
AU·9 granted patents·6 pending applications·5 citations·filing 2004–2024
Top patents by PatentIndex Score
15 records- 0177US2024392301A1Therapeutic uses and methodsANTISENSE THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0276US9717778B2Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2013·Granted Aug 1, 2017·3 cites·21 claims
- 0364US2022047679A1Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0463US11976281B2Therapeutic uses and methodsANTISENSE THERAPEUTICS LTD·Filed 2019·Granted May 7, 2024·0 cites·13 claims
- 0563US7468356B2Modulation of insulin like growth factor I receptor expressionANTISENSE THERAPEUTICS LTD·Filed 2004·Granted Dec 23, 2008·2 cites·29 claims
- 0661US9371530B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionANTISENSE THERAPEUTICS LTD·Filed 2013·Granted Jun 21, 2016·0 cites·7 claims
- 0759US9885048B2Method for reducing circulating leukocytes in a human subjectANTISENSE THERAPEUTICS LTD·Filed 2016·Granted Feb 6, 2018·0 cites·8 claims
- 0856US9988635B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionANTISENSE THERAPEUTICS LTD·Filed 2016·Granted Jun 5, 2018·0 cites·12 claims
- 0956US2009111767A1Modulation of insulin like growth factor i receptor expressionANTISENSE THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 1052US11041156B2Mobilizing leukemia cellsANTISENSE THERAPEUTICS LTD·Filed 2018·Granted Jun 22, 2021·0 cites·16 claims
- 1151US2016129089A1Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 1250US2022296631A1Methods for treating muscular dystrophy using inhibitory oligonucleotides to cd49dANTISENSE THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1348US9821034B2Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2016·Granted Nov 21, 2017·0 cites·21 claims
- 1446US11891606B2Methods for treating multiple sclerosis using antisense oligonucleotidesANTISENSE THERAPEUTICS LTD·Filed 2018·Granted Feb 6, 2024·0 cites·21 claims
- 1544US2015344890A1Modulation of Insulin Like Growth Factor I Receptor Expression in CancerANTISENSE THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANTISENSE THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →